Stocks
NovoCure LimitedNVCR
NASDAQHealthcareMedical Devices$12.06+0.42%
Developer of oncology devices that use tumor treating fields, a therapy that delivers low‑intensity electric fields to disrupt cancer cell division. Its flagship Optune system is approved for certain brain cancers and is being studied across additional tumor types, placing the company at the interse...
Market Cap: $1.4B52W Range: $9.82 – $20.06
Congressional Interest in NovoCure Limited (NVCR)
2 members of Congress have disclosed 2 trades in NovoCure Limited (NVCR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading NVCR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-09-15 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2021-07-02 | Marie Newman | buy | $15K – $50K |